Johnson & Johnson (JNJ) — Stock Score Summary

Johnson & Johnson (JNJ) has a MoatMap StockRank of 84/100 based on Quality (69/100), Value (34/100), and Momentum (64/100) factor scores. The current signal is STRONG BUY. Johnson & Johnson is a defensive giant but lacks the high-velocity macro tailwinds required for our concentrated 18-month strategy. It is a slow grower that does not benefit from the CDMO pricing power cycle directly.

Johnson & Johnson is a diversified global healthcare giant focused on Pharmaceuticals and MedTech. It develops and sells prescription drugs and a wide array of medical devices used in surgery, orthopedics, and other specialties. The company benefits from unparalleled global scale, extensive R&D capabilities, a vast portfolio of leading products, and strong distribution networks, maintaining a market leader position in many healthcare segments.

Key Financial Metrics

Price$228.17
Market Cap$555.6B
P/E (TTM)26.47
P/E (Forward)17.94
Price/Book6.76
Return on Equity26.4%
Return on Invested Capital23.1%
Debt/Equity67.73
Gross Margin68.0%
Operating Margin27.4%
Revenue Growth9.9%
Dividend Yield2.4%
Free Cash Flow$12.5B

Johnson & Johnson operates in the Drug Manufacturers - General industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Johnson & Johnson’s (JNJ) StockRank?
MoatMap’s StockRank for Johnson & Johnson (JNJ) is 84/100, with a Strong Buy signal. It is a composite of Quality (69), Value (34), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Johnson & Johnson have an economic moat?
Johnson & Johnson (JNJ) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Johnson & Johnson a buy, hold, or sell?
MoatMap’s current signal for Johnson & Johnson (JNJ) is Strong Buy, based on a StockRank of 84/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Johnson & Johnson in?
Johnson & Johnson (JNJ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (United States).
Browse all ranked stocksJNJ deep dive reportAI ChampionsHow we score stocksSense-check another stock